Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of chronic schizophrenic disorder, according to the Diagnostic and Statistical Manual of Mental Diseases, 3rd edition (DSM-III-R) criteria~* total score on the PANSS at study entry of \>=60 and \<=120~* physical and neurological examination and ECG findings and clinical hematology, biochemistry, and urinalysis test results within normal limits before study entry~* patients must be able to be hospitalized the first 3 weeks of the study, if possible.~Exclusion Criteria:~* Patients with mental disorders other than chronic schizophrenic disorder~* patients with clinically significant organic or neurologic diseases~* women who are pregnant or breastfeeding, and women of childbearing potential without adequate birth control measures~* patients with epilepsy~* history of alcohol or drug abuse history within the previous 12 months.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).